<DOC>
	<DOC>NCT01238328</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and side effects of donor hematopoietic cells using chemotherapy regimen without total-body irradiation in children undergoing a hematopoietic stem cell transplant for Mucopolysaccharidosis. The blood stem cells will be derived from either related donor or unrelated umbilical cord blood or haploidentical donor.</brief_summary>
	<brief_title>Hematopoietic Stem Cell Transplantation for Mucopolysaccharidosis</brief_title>
	<detailed_description />
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<criteria>Diagnosis of Mucopolysaccharidosis type 1, 6 and 7 confirm by leukocyte enzyme assay Age up to 8 year old Have suitable donor Creatinine clearance ≤ 40ml/min/1.73m^2 Bilirubin ≥ 3mg/dL SGPT ≥ 500 U/L Current severe infection Evidence of CNS involvement Morbidity such as blindness or deafness</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Mucopolysaccharidosis</keyword>
	<keyword>HSCT</keyword>
</DOC>